S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
Log in
NASDAQ:NCSM

NCS Multistage Stock Forecast, Price & News

$1.02
-0.10 (-8.93 %)
(As of 11/30/2020 04:30 PM ET)
Add
Compare
Today's Range
$1.00
Now: $1.02
$1.12
50-Day Range
$0.61
MA: $0.79
$1.17
52-Week Range
$0.31
Now: $1.02
$2.35
Volume115,467 shs
Average Volume126,088 shs
Market Capitalization$48.14 million
P/E RatioN/A
Dividend YieldN/A
Beta2.05
NCS Multistage Holdings, Inc. provides engineered products and support services for oil and natural gas well completions and field development strategies in the United States, Canada, and internationally. Its products include casing-installed sliding sleeves, downhole frac isolation assemblies, sand jet perforating products, spotfrac systems, ballshift sliding sleeves, airlock casing buoyancy systems, liner hanger systems, and spectrum tracer services. The company also provides advisory services to customers on completion designs and field development strategies. It offers its products and services primarily to exploration and production companies for use in onshore wells through technically-trained direct sales force, and operating partners or sales representatives. The company was formerly known as Pioneer Super Holdings, Inc. and changed its name to NCS Multistage Holdings, Inc. in December 2016. NCS Multistage Holdings, Inc. was founded in 2006 and is headquartered in Houston, Texas.
NCS Multistage logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.64 out of 5 stars


Industry, Sector and Symbol

Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
Current SymbolNASDAQ:NCSM
CUSIPN/A
Phone281-453-2222
Employees394

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$205.49 million
Book Value$3.49 per share

Profitability

Net Income$-32,820,000.00

Miscellaneous

Market Cap$48.14 million
Next Earnings Date3/1/2021 (Estimated)
OptionableNot Optionable
$1.02
-0.10 (-8.93 %)
(As of 11/30/2020 04:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NCSM News and Ratings via Email

Sign-up to receive the latest news and ratings for NCSM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











NCS Multistage (NASDAQ:NCSM) Frequently Asked Questions

How has NCS Multistage's stock been impacted by COVID-19?

NCS Multistage's stock was trading at $1.11 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NCSM stock has decreased by 8.1% and is now trading at $1.02.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of NCS Multistage?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NCS Multistage in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for NCS Multistage
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than NCS Multistage?

Wall Street analysts have given NCS Multistage a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but NCS Multistage wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is NCS Multistage's next earnings date?

NCS Multistage is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021.
View our earnings forecast for NCS Multistage
.

How were NCS Multistage's earnings last quarter?

NCS Multistage Holdings, Inc. (NASDAQ:NCSM) posted its quarterly earnings results on Wednesday, November, 4th. The company reported ($0.10) EPS for the quarter, topping analysts' consensus estimates of ($0.17) by $0.07. The business earned $16.31 million during the quarter, compared to the consensus estimate of $15 million. NCS Multistage had a negative return on equity of 13.07% and a negative net margin of 51.90%.
View NCS Multistage's earnings history
.

What price target have analysts set for NCSM?

4 equities research analysts have issued twelve-month price objectives for NCS Multistage's shares. Their forecasts range from $0.55 to $2.50. On average, they expect NCS Multistage's share price to reach $1.38 in the next year. This suggests a possible upside of 35.6% from the stock's current price.
View analysts' price targets for NCS Multistage
.

Who are some of NCS Multistage's key competitors?

What other stocks do shareholders of NCS Multistage own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NCS Multistage investors own include Allena Pharmaceuticals (ALNA), CNX Resources (CNX), Diebold Nixdorf (DBD), Energy Transfer (ET), Huntington Bancshares (HBAN), KeyCorp (KEY), People's United Financial (PBCT), Primo Water (PRMW), Palatin Technologies (PTN) and Transocean (RIG).

Who are NCS Multistage's key executives?

NCS Multistage's management team includes the following people:
  • Mr. Robert Nipper, CEO & Director (Age 56, Pay $453.69k)
  • Mr. Ryan Hummer, CFO & Treasurer (Age 42, Pay $365.45k)
  • Mr. Tim Willems, Chief Operations Officer (Age 58)
  • Ms. Lori A. Cole, VP of Fin. & Principal Accounting Officer
  • Mr. John Ravensbergen P.Eng., Chief Technology Officer (Age 54)
  • Mr. P. Kevin Trautner, Chief Legal Officer & Sec. (Age 53)
  • Mr. Roger Dwyer, Exec. VP of HSE (Age 46)
  • Mr. Dustin Ellis, Sr. VP of U.S. Operations & Tech Services (Age 42)
  • Mr. James Gambrell King, Chief Strategy Officer (Age 54)
  • Mr. Donald R. Battenfelder, Pres of North American Operations (Age 60)

When did NCS Multistage IPO?

(NCSM) raised $157 million in an initial public offering (IPO) on Friday, April 28th 2017. The company issued 9,500,000 shares at a price of $15.00-$18.00 per share. Credit Suisse, Citigroup and Wells Fargo Securities acted as the underwriters for the IPO and J.P. Morgan, Simmons & Company International Energy ((Specialist of Piper Jaffray) Raymond James, RBC Capital Markets and Tudor, Pickering, Holt were co-managers.

What is NCS Multistage's stock symbol?

NCS Multistage trades on the NASDAQ under the ticker symbol "NCSM."

Who are NCS Multistage's major shareholders?

NCS Multistage's stock is owned by a number of institutional and retail investors. Top institutional investors include ArrowMark Colorado Holdings LLC (4.62%). Company insiders that own NCS Multistage stock include Franklin Myers, John D Deane, Kevin Trautner, Marty Stromquist and Ryan Hummer.
View institutional ownership trends for NCS Multistage
.

Which major investors are selling NCS Multistage stock?

NCSM stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC.
View insider buying and selling activity for NCS Multistage
.

How do I buy shares of NCS Multistage?

Shares of NCSM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NCS Multistage's stock price today?

One share of NCSM stock can currently be purchased for approximately $1.02.

How big of a company is NCS Multistage?

NCS Multistage has a market capitalization of $48.14 million and generates $205.49 million in revenue each year. The company earns $-32,820,000.00 in net income (profit) each year or ($0.24) on an earnings per share basis. NCS Multistage employs 394 workers across the globe.

What is NCS Multistage's official website?

The official website for NCS Multistage is www.ncsmultistage.com.

How can I contact NCS Multistage?

NCS Multistage's mailing address is 19350 STATE HIGHWAY 249 SUITE 600, HOUSTON TX, 77070. The company can be reached via phone at 281-453-2222 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.